Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
The medicine is only on the complementary list. For these items specialized diagnostic or monitoring or specialist training are needed. An item may also be listed as complementary on the basis of higher costs or a less attractive cost-benefit ratio.
Ethionamide is a recognized second-line antituberculosis medication and is part of the WHO-recommended treatments for rifampicin-resistant and multidrug-resistant Tuberculosis (TB). However, it is not among the select first-line agents that are specifically highlighted as FDA-licensed for standard drug-susceptible TB, which include rifampin, isoniazid, [pyraz…